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LETTERS TO THE EDITOR 
Cryopreserved homograft monoeusp valves for 
reconstruction of the right ventricular outflow 
tract 
To the Editor." 
Bigras and associates I presented their data with the use 
of monocusp valves in repair of tetralogy of Fallot in the 
July issue of the Journal. They concluded that transannu- 
lar patch repair with three different monocusp valves, 
used to reconstruct the pulmonary valve orifice or the 
right ventricular outflow tract 2 standard deviations 
smaller than normal, neither prevents hort-term postop- 
erative pulmonary insufficiency nor improves immediate 
postoperative outcome. Monocusp valves tailored too 
wide were believed to be one cause of the observed early 
postoperative pulmonary insufficiency. 
Since July 1990 we have used cryopreserved valved 
homografts to reconstruct the right ventricular outflow 
tract (RVOT) in 65 patients (mean ge 4.3 years; range 3 
months to 36 years) with tetralogy of Fallot (27/65; 42%), 
double-outlet right ventricle (15/63; 23%), pulmonary 
atresia (10/65; 15%), congenitally corrected transposition 
of the great arteries (3/65; 5%), truncus arteriosus (5/65; 
6%), and complex pulmonary stenosis (5/65; 6%). Ho- 
mograft conduits (29/65; 45%) were used if the RVOT 
was missing or not suitable for surgical in situ reconstruc- 
tion owing to severe malformation. A transannular mono- 
cusp homograft patch (36/65; 55%) was used if age- 
related dimensions of the RVOT measured uring the 
operation by Hegar dilators could not be achieved either 
by infundibular resection or commissurotomy. In growing 
patients the largest size homograft technically implantable 
was used at times. The operative mortality was 9.2% and 
was due to low cardiac output in six patients and to sepsis 
in one. The mean pressure gradient over the RVOT was 
successfully reduced from 70 + 22 mm Hg to 10 mm Hg. 
As in Bigras' study, the pulmonary valve insufficiency 
(assessed by color flow Doppler echocardiography) was 
significant. In the early postoperative period, moderate 
pulmonary insufficiency was found in 48% of monocusps 
and moderate to severe insufficiency in 24%. After 34 _+ 
!3 months (range 14 to 60), moderate to severe pulmo- 
nary regurgitation was found in 52% of monocusps but in 
only 8% of valved homograft conduits (p = 0.005). As 
suggested by Bigras and associates, 1 the degree of over- 
sizing in monocusp valves was significantly associated with 
the development of late pulmonary regurgitation (r = 
0.86; p = 0.005). One child had to be reoperated on after 
18 months because of aneurysmal dilatation of a ho- 
mograft conduit causing severe pulmonary regurgitation. 
In six of 52 (1.1.5%) children, two with a valved conduit 
and four with a monocusp valve, severe stenosis at the 
distal homograft-pulmonary artery anastomosis devel- 
oped after 16 :_+ 4 months, necessitating balloon dilatation 
or reoperation in three patients each. Explanted ho- 
mografts were acellular, nonvital, and calcified. Immuno- 
histochemistry evealed the presence of T-cell as well as 
B-cell lymphocytes. 
Pericardial monocusp valves used for RVOT recon- 
struction are reported to provide excellent early hemody- 
namic function. 2 Nevertheless, the study presented by 
Bigras and coworkers, 1 as well as our own results, 3 fails to 
demonstrate an improved outcome with the use of mono- 
cusp valves. Late monocusp valve regurgitation is signifi- 
cant, which might be reduced by avoiding monocusp 
oversizing. In the case of a missing or severely diseased 
RVOT, reconstruction with a cryopreserved homograft 
conduit achieves good surgical results. 4 However, the use 
of cryopreserved monocusp homografts fails to prevent 
pulmonary regurgitation either early and late after the 
operation. Furthermore, a disturbingly high incidence of 
late distal anastomotic stenosis was observed when mono- 
cusp valves were used to enlarge the pulmonary artery, 
which led us to abandon this particular technique for 
RVOT reconstruction. 
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12/8/78043 
Cost reduction by combined carotid 
endarterectomy and coronary bypass 
To the Editor." 
I read with great interest the article by Daily and 
associates 1 in the June 1996 issue of the Journal, in which 
they examined the cost effectiveness of doing first-time 
isolated carotid endarterectomy, coronary bypass, or corn- 
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